To more precisely evaluate TAGLN2, TPI-1, and ENO1 expression by gynecological cancers, western blotting was carried out using proteins extracted from the 3 primary and 3 metastatic tumors. This evidence concerns the gene TPI1 and female reproductive organ cancer.